{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:43:45Z","timestamp":1777499025593,"version":"3.51.4"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100007388","name":"Compagnia di San Paolo","doi-asserted-by":"publisher","award":["2012.1020"],"award-info":[{"award-number":["2012.1020"]}],"id":[{"id":"10.13039\/100007388","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e0 degli studi di Catania","award":["Piano della Ricerca di Ateneo 2016-2018"],"award-info":[{"award-number":["Piano della Ricerca di Ateneo 2016-2018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11095-019-2636-1","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T22:20:07Z","timestamp":1559600407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Fibrin Gels Entrapment of a Poly-Cyclodextrin Nanocarrier as a Doxorubicin Delivery System in an Orthotopic Model of Neuroblastoma: Evaluation of In Vitro Activity and In Vivo Toxicity"],"prefix":"10.1007","volume":"36","author":[{"given":"Maurizio","family":"Viale","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graziella","family":"Vecchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimiliano","family":"Monticone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Bertone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Giglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irena","family":"Maric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Cilli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vittorio","family":"Bocchini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aldo","family":"Profumo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirco","family":"Ponzoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Emionite","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia","family":"Rocco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,6,3]]},"reference":[{"key":"2636_CR1","first-page":"719","volume-title":"The molecular basis of blood diseases","author":"RF Doolittle","year":"2000","unstructured":"Doolittle RF. The molecular biology of fibrin. In: Stamatoyannopoulos G, Majerus PW, Perlmutter RM, Varmus H, editors. The molecular basis of blood diseases. Philadelphia: Saunders; 2000. p. 719\u201339."},{"key":"2636_CR2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0065-3233(05)70008-5","volume":"70","author":"JW Weisel","year":"2005","unstructured":"Weisel JW. Fibrinogen and fibrin. Adv Protein Chem. 2005;70:247\u201399.","journal-title":"Adv Protein Chem"},{"issue":"6","key":"2636_CR3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.5301\/ejo.5000466","volume":"24","author":"C K\u00fc\u00e7\u00fckerd\u00f6nmez","year":"2014","unstructured":"K\u00fc\u00e7\u00fckerd\u00f6nmez C, Karalezli A, Zengin MO, Akova YA. Vascularization of conjunctival autografts in pterygium surgery: comparison of fibrin glue with sutures. Eur J Ophthalmol. 2014;24(6):824\u20139.","journal-title":"Eur J Ophthalmol"},{"issue":"2","key":"2636_CR4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/1010-7940(93)90184-D","volume":"7","author":"C Mouritzen","year":"1993","unstructured":"Mouritzen C, Dromer M, Keinecke HO. The effect of fibrin glueing to seal bronchial and alveolar leakages after pulmonary resection and decortications. Eur J Cardithorac Surg. 1993;7(2):75\u201380.","journal-title":"Eur J Cardithorac Surg"},{"issue":"3","key":"2636_CR5","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4103\/0970-0358.122011","volume":"46","author":"MA Tashnizi","year":"2013","unstructured":"Tashnizi MA, Alamdari DH, Khayami ME, Rahimi HR, Moeinipour A, Amouzeshi A, et al. Treatment of non-healing sternum wound after open-heart surgery with allogenic platelet-rich plasma and fibrin glue-preliminary outcomes. Indian J Plast Surg. 2013;46(3):538\u201342.","journal-title":"Indian J Plast Surg"},{"key":"2636_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1749-6632.1983.tb23248.x","volume":"408","author":"M Okada","year":"1983","unstructured":"Okada M, Blomb\u00e4ck B. Factors influencing fibrin gel structure studied by flow measurement. Ann N Y Acad Sci. 1983;408:233\u201353.","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"2636_CR7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.transci.2007.12.005","volume":"38","author":"AS Wolberg","year":"2008","unstructured":"Wolberg AS, Campbell RA. Thrombin generation, fibrin clot formation and hemostasis. Transfus Apher Sci. 2008;38(1):15\u201323.","journal-title":"Transfus Apher Sci"},{"issue":"3","key":"2636_CR8","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jconrel.2010.01.010","volume":"143","author":"YI Chung","year":"2010","unstructured":"Chung YI, Kim SK, Lee YK, Park SJ, Cho KO, Yuk SH, et al. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle\u2013fibrin complex. J Control Release. 2010;143(3):282\u20139.","journal-title":"J Control Release"},{"issue":"6","key":"2636_CR9","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S0344-0338(86)80051-6","volume":"181","author":"HP Dinges","year":"1986","unstructured":"Dinges HP, Redl H, Thurnher M, Schiesser A, Schlag G. Morphometric studies on wound healing after systemic administration of adriamycin and local application of fibrin sealant: application of a new wound healing model using spongiosa implants. Path Res Pract. 1986;181(6):746\u201354.","journal-title":"Path Res Pract"},{"issue":"5","key":"2636_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.copbio.2003.09.004","volume":"14","author":"JA Hubbell","year":"2003","unstructured":"Hubbell JA. Materials as morphogenetic guides in tissue engineering. Curr Opin Biotechnol. 2003;14(5):551\u20138.","journal-title":"Curr Opin Biotechnol"},{"issue":"34","key":"2636_CR11","doi-asserted-by":"crossref","first-page":"9106","DOI":"10.1016\/j.biomaterials.2010.08.016","volume":"31","author":"Y Lei","year":"2010","unstructured":"Lei Y, Huang S, Sharif-Kashani P, Chen Y, Kavehpour P, Segura T. Incorporation of active DNA\/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials. 2010;31(34):9106\u201316.","journal-title":"Biomaterials"},{"issue":"1","key":"2636_CR12","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.surg.2005.11.012","volume":"140","author":"Y Ogura","year":"2006","unstructured":"Ogura Y, Mizumoto K, Tanaka M, Ohuchida K, Murakami M, Yamada D, et al. Strategy for prevention of local recurrence of pancreatic cancer after pancreatectomy: antitumor effect of gemcitabine mixed with fibrin glue in an orthotopic nude mouse model. Surgery. 2006;140(1):66\u201371.","journal-title":"Surgery"},{"issue":"1","key":"2636_CR13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jtcvs.2010.09.032","volume":"141","author":"I Opitz","year":"2011","unstructured":"Opitz I, Erne BV, Demirbas S, Jetter A, Seifert B, Stahel R, et al. Optimized intrapleural cisplatin chemotherapy with a fibrin carrier after extrapleural pneumonectomy: a preclinical study. J Thorac Cardiovasc Surg. 2011;141(1):65\u201371.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2636_CR14","first-page":"3641","volume":"8","author":"T Rajangam","year":"2013","unstructured":"Rajangam T, An SS. Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications. Int J Nanomedicine. 2013;8:3641\u201362.","journal-title":"Int J Nanomedicine"},{"issue":"6","key":"2636_CR15","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s10637-015-0291-x","volume":"33","author":"M Viale","year":"2015","unstructured":"Viale M, Rossi M, Russo E, Cilli M, Aprile A, Profumo A, et al. Fibrin gels loaded with cisplatin and cisplatin-hyaluronate complexes tested in a subcutaneous human melanoma model. Investig New Drugs. 2015;33(6):1151\u201361.","journal-title":"Investig New Drugs"},{"issue":"5","key":"2636_CR16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10637-017-0461-0","volume":"35","author":"M Viale","year":"2017","unstructured":"Viale M, Giglio V, Monticone M, Maric I, Lentini G, Rocco M, et al. New doxorubicin nanocarriers based on cyclodextrins. Invest New Drug. 2017;35(5):539\u201344.","journal-title":"Invest New Drug"},{"issue":"6","key":"2636_CR17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.3322\/caac.21199","volume":"63","author":"AS Thakor","year":"2013","unstructured":"Thakor AS, Gambhir SS. Nanooncology: the future of cancer diagnosis and therapy. CA Cancer J Clin. 2013;63(6):395\u2013418.","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2636_CR18","doi-asserted-by":"crossref","first-page":"pii E594","DOI":"10.3390\/ijms18030594","volume":"18","author":"J Key","year":"2017","unstructured":"Key J, Park K. Multicomponent, tumor-homing chitosan nanoparticles for cancer imaging and therapy. Int J Mol Sci. 2017;18(3):pii E594.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"2636_CR19","first-page":"198","volume":"31","author":"MS Lee","year":"2017","unstructured":"Lee MS, Dees EC, Wang AZ. Nanoparticle-delivered chemotherapy: old drugs in new packages. Oncology (Williston Park). 2017;31(3):198\u2013208.","journal-title":"Oncology (Williston Park)"},{"key":"2636_CR20","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.colsurfb.2013.09.035","volume":"114","author":"B Gidwani","year":"2014","unstructured":"Gidwani B, Vyas A. Synthesis, characterization and application of epichlorohydrin-\u03b2-cyclodextrin polymer. Colloids Surf B. 2014;114:130\u20137.","journal-title":"Colloids Surf B"},{"key":"2636_CR21","doi-asserted-by":"crossref","unstructured":"Ruiz-Esparza GU, Wu S, Segura-Ibarra V, Cara FE, Evans KW, Milosevic M, et al. Polymer nanoparticles encased in a cyclodextrin complex shell for potential site- and sequence-specific drug release. Adv Funct Mater. 2014;24(30):4753\u201361.","DOI":"10.1002\/adfm.201400011"},{"issue":"8","key":"2636_CR22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/10610278.2013.794278","volume":"25","author":"V Oliveri","year":"2013","unstructured":"Oliveri V, D\u2019Agata R, Giglio V, Spoto G, Vecchio G. Cyclodextrin-functionalised gold nanoparticles via streptavidin: a supramolecular approach. Supramol Chem. 2013;25(8):465\u201373.","journal-title":"Supramol Chem"},{"issue":"18","key":"2636_CR23","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1002\/chem.201700031","volume":"23","author":"G Oliveri","year":"2017","unstructured":"Oliveri G, Bellia F, Vecchio G. Cyclodextrin nanoparticles bearing 8-hydroxyquinoline ligands as multifunctional biomaterials. Chemistry. 2017;23(18):4442\u20139.","journal-title":"Chemistry."},{"issue":"4","key":"2636_CR24","first-page":"579","volume":"8","author":"Shankar Swaminathan","year":"2016","unstructured":"Swaminathan S, Cavalli R, Trotta F. Cyclodextrin-based nanosponges: a versatile platform for cancer nanotherapeutics development. WIREs Nanomed Nanobiotechnol. 2016;8(4):579\u2013601.","journal-title":"Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology"},{"key":"2636_CR25","doi-asserted-by":"crossref","first-page":"262731","DOI":"10.1155\/2012\/262731","volume":"2012","author":"JD Heidel","year":"2012","unstructured":"Heidel JD, Schluep T. Cyclodextrin-containing polymers: versatile platforms of drug delivery materials. J Drug Deliv. 2012;2012:262731.","journal-title":"J Drug Deliv"},{"issue":"22","key":"2636_CR26","doi-asserted-by":"crossref","first-page":"16664","DOI":"10.1039\/C4RA16064A","volume":"5","author":"Valentina Giglio","year":"2015","unstructured":"Giglio V, Sgarlata C, Vecchio G, Novel amino-cyclodextrin cross-linked oligomer as efficient carrier for anionic drugs: a spectroscopic and nanocalorimetric investigation. RSC Adv. 2015;5:16664\u201371.","journal-title":"RSC Advances"},{"issue":"4","key":"2636_CR27","first-page":"760","volume":"70","author":"M Viale","year":"2018","unstructured":"Viale M, Monticone M, Maric I, Giglio V, Profumo A, Aprile A, et al. Characterization of drug release from fibrin gels loaded with different pharmaceutical and experimental doxorubicin formulations. Invest New Drug. 2018;70(4):760\u20135.","journal-title":"Invest New Drug"},{"issue":"29","key":"2636_CR28","doi-asserted-by":"crossref","first-page":"3070","DOI":"10.2174\/092986707782793916","volume":"14","author":"F Pastorino","year":"2007","unstructured":"Pastorino F, Marimpietri D, Brignole C, Di Paolo D, Pagnan G, Daga A, et al. Ligand targeted liposomal therapies of neuroblastoma. Curr Med Chem. 2007;14(29):3070\u20138.","journal-title":"Curr Med Chem"},{"issue":"12","key":"2636_CR29","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1016\/j.amjcard.2013.08.026","volume":"112","author":"M Lotrionte","year":"2013","unstructured":"Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, et al. Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol. 2013;112(12):1980\u20134.","journal-title":"Am J Cardiol"},{"key":"2636_CR30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.taap.2016.09.012","volume":"310","author":"G. Ronald Jenkins","year":"2016","unstructured":"Jenkins GR, Lee T, Moland CL. Vijay V, Herman EH, Lewis SM, Davis KJ, Muskhelishvili L, Kerr S, Fuscoe JC, Desai VG.. Sex-related differential susceptibility to doxorubicin-induced cardiotoxicity in B6C3F1 mice. Toxicol Appl Pharmacol 2016;310:159\u2013174.","journal-title":"Toxicology and Applied Pharmacology"},{"key":"2636_CR31","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.carbpol.2017.08.103","volume":"177","author":"V Oliveri","year":"2017","unstructured":"Oliveri V, Bellia F, Viale M, Maric I, Vecchio G. Linear polymers of \u03b2 and \u03b3 cyclodextrins with a polyglutamic acid backbone as carriers for doxorubicin. Carbohydr Polym. 2017;177:355\u201360.","journal-title":"Carbohydr Polym"},{"issue":"15","key":"2636_CR32","doi-asserted-by":"crossref","first-page":"12461","DOI":"10.1039\/C5RA22398A","volume":"6","author":"V Giglio","year":"2016","unstructured":"Giglio V, Viale M, Monticone M, Aura AM, Spoto G, Natile G, et al. Cyclodextrin polymers as carries for the platinum-based anticancer agent LA-12. RSC Adv. 2016;6(15):12461\u20136.","journal-title":"RSC Adv"},{"issue":"3","key":"2636_CR33","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/s10637-017-0538-9","volume":"36","author":"V Giglio","year":"2018","unstructured":"Giglio V, Viale M, Bertone V, Maric I, Vaccarone R, Vecchio G. Cyclodextrin polymers as nanocarriers for sorafenib. Invest New Drug. 2018;36(3):370\u20139.","journal-title":"Invest New Drug"},{"issue":"14","key":"2636_CR34","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.2174\/092986711795656243","volume":"18","author":"JR Kanwar","year":"2011","unstructured":"Kanwar JR, Long BM, Kanwar RK. The use of cyclodextrins nanoparticles for oral delivery. Curr Med Chem. 2011;18(14):2079\u201385.","journal-title":"Curr Med Chem"},{"issue":"22","key":"2636_CR35","doi-asserted-by":"crossref","first-page":"16664","DOI":"10.1039\/C4RA16064A","volume":"5","author":"V Giglio","year":"2015","unstructured":"Giglio V, Sgarlata C, Vecchio G. Novel amino-cyclodextrin cross-linked oligomer as efficient carrier for anionic drugs: a spectroscopic and nanocalorimetric investigation. RSC Adv. 2015;5(22):16664\u201371.","journal-title":"RSC Adv"},{"issue":"6","key":"2636_CR36","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1053\/j.sempedsurg.2016.10.003","volume":"25","author":"AM Davidoff","year":"2016","unstructured":"Davidoff AM, Fernandez-Pineda I. Complications in the surgical management of children with malignant solid tumors. Sem Ped Surg. 2016;25(6):395\u2013403.","journal-title":"Sem Ped Surg"},{"issue":"2","key":"2636_CR37","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-016-3195-3","volume":"79","author":"C Gerardi","year":"2017","unstructured":"Gerardi C, Banzi R, Bertele\u2019 V, Garattini S. Clinical research on rare diseases of children: neuroblastoma. Cancer Chemother Pharmacol. 2017;79(2):267\u201373.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"22","key":"2636_CR38","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1200\/JCO.2016.72.0177","volume":"35","author":"JR Park","year":"2017","unstructured":"Park JR, Bagatell R, Cohn SL, Pearson AD, Villablanca JG, Berthold F, et al. Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute clinical trials planning meeting. J Clin Oncol. 2017;35(22):2580\u20137.","journal-title":"J Clin Oncol"},{"issue":"4","key":"2636_CR39","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/pbc.22344","volume":"54","author":"P Bensimhon","year":"2010","unstructured":"Bensimhon P, Villablanca JG, Sender LS, Matthay KK, Park JR, Seeger R, et al. Peripheral blood stem cell support for multiple cycles of dose intensive induction therapy is feasible with little risk of tumor contamination in advanced stage neuroblastoma: a report from the Childrens oncology group. Pediatr Blood Cancer. 2010;54(4):596\u2013602.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"2636_CR40","first-page":"26","volume":"32","author":"HC Tran","year":"2015","unstructured":"Tran HC, Marachelian A, Venkatramani R, Jubran RF, Mascarenhas L. Oxaliplatin and doxorubicin for relapsed or refractory high-risk neuroblastoma. Hematol Oncol. 2015;32(1):26\u201331.","journal-title":"Hematol Oncol"},{"issue":"5","key":"2636_CR41","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1080\/1120009X.1989.11738916","volume":"1","author":"A Balsari","year":"1989","unstructured":"Balsari A, Lombardo N, Ghione M. Skin and perivascular toxicity induced experimentally by doxorubicin. J Chemother. 1989;1(5):324\u20139.","journal-title":"J Chemother"},{"issue":"2","key":"2636_CR42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF00273522","volume":"23","author":"JA Balazsovits","year":"1989","unstructured":"Balazsovits JA, Mayer LD, Bally MB, Cullis PR, McDonell M, Ginsberg RS, et al. Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin. Cancer Chemother Pharmacol. 1989;23(2):81\u20136.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"6","key":"2636_CR43","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1038\/bjc.1985.267","volume":"52","author":"G Pratesi","year":"1985","unstructured":"Pratesi G, Savi G, Pezzoni G, Bellini O, Penco S, Tinelli S, et al. Poly-L-aspartic acid as a carrier for doxorubicin: a comparative in vivo study of free and polymer-bound drug. Br J Cancer. 1985;52(6):841\u20138.","journal-title":"Br J Cancer"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2636-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2636-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,16]],"date-time":"2020-12-16T23:28:38Z","timestamp":1608161318000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2636-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,3]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2636"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2636-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,3]]},"assertion":[{"value":"24 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"115"}}